SEC Company Response from AXM PHARMA INC (CIK 0001113643) — May 27, 2005
AXM PHARMA INC (CIK 0001113643)
Date: May 27, 2005 · CIK: 0001113643 · Accession: 0001121781-05-000144
AI Filing Summary & Sentiment
Letter
Division of Corporate Finance Washington, D.C. 20549-0303 Re: AXM Pharma, Inc. Schedule 14A Information
Dear Sir or Madam:
We are counsel to AXM Pharma, Inc. (the “Company”). On behalf of our client, enclosed herewith please find a Definitive Schedule 14A for the Company.
The Company sent copies of the Schedule to its security holders on May 27, 2005.
Please feel free to contact the undersigned if you have any questions regarding the filing or this letter.
Very truly yours,
Law Offices of
Show Raw Text
CORRESP 1 filename1.htm AXM Pharma, Inc. Def 14A Cover Letter LAW OFFICES OF LOUIS E. TAUBMAN, P.C. 225 Broadway, Suite 1200 New York, New York 10007 (212) 732-7184 Fax: (212) 202-6380 E-mail: Louistlaw@aol.com May 27, 2005 U.S. Securities and Exchange Commission Division of Corporate Finance 450 Fifth Street, N.W. Washington, D.C. 20549-0303 Re: AXM Pharma, Inc. Schedule 14A Information Dear Sir or Madam: We are counsel to AXM Pharma, Inc. (the “Company”). On behalf of our client, enclosed herewith please find a Definitive Schedule 14A for the Company. The Company sent copies of the Schedule to its security holders on May 27, 2005. Please feel free to contact the undersigned if you have any questions regarding the filing or this letter. Very truly yours, Law Offices of Louis Taubman /s/ Rachael Hymes Rachael Hymes Enclosure